Department of Molecular Genetics and Microbiology and Center for Microbial Pathogenesis, Duke University Medical Center, Durham, North Carolina, United States of America ; Department of Biochemistry, Duke University Medical Center, Durham, North Carolina, United States of America.
Department of Molecular Genetics and Microbiology and Center for Microbial Pathogenesis, Duke University Medical Center, Durham, North Carolina, United States of America.
PLoS Pathog. 2014 Feb 20;10(2):e1003954. doi: 10.1371/journal.ppat.1003954. eCollection 2014 Feb.
Chlamydia trachomatis, the causative agent of trachoma and sexually transmitted infections, employs a type III secretion (T3S) system to deliver effector proteins into host epithelial cells to establish a replicative vacuole. Aside from the phosphoprotein TARP, a Chlamydia effector that promotes actin re-arrangements, very few factors mediating bacterial entry and early inclusion establishment have been characterized. Like many T3S effectors, TARP requires a chaperone (Slc1) for efficient translocation into host cells. In this study, we defined proteins that associate with Slc1 in invasive C. trachomatis elementary bodies (EB) by immunoprecipitation coupled with mass spectrometry. We identified Ct875, a new Slc1 client protein and T3S effector, which we renamed TepP (Translocated early phosphoprotein). We provide evidence that T3S effectors form large molecular weight complexes with Scl1 in vitro and that Slc1 enhances their T3S-dependent secretion in a heterologous Yersinia T3S system. We demonstrate that TepP is translocated early during bacterial entry into epithelial cells and is phosphorylated at tyrosine residues by host kinases. However, TepP phosphorylation occurs later than TARP, which together with the finding that Slc1 preferentially engages TARP in EBs leads us to postulate that these effectors are translocated into the host cell at different stages during C. trachomatis invasion. TepP co-immunoprecipitated with the scaffolding proteins CrkI-II during infection and Crk was recruited to EBs at entry sites where it remained associated with nascent inclusions. Importantly, C. trachomatis mutants lacking TepP failed to recruit CrkI-II to inclusions, providing genetic confirmation of a direct role for this effector in the recruitment of a host factor. Finally, endocervical epithelial cells infected with a tepP mutant showed altered expression of a subset of genes associated with innate immune responses. We propose a model wherein TepP acts downstream of TARP to recruit scaffolding proteins at entry sites to initiate and amplify signaling cascades important for the regulation of innate immune responses to Chlamydia.
沙眼衣原体是导致沙眼和性传播感染的病原体,它利用 III 型分泌系统(T3S)将效应蛋白输送到宿主上皮细胞中,以建立复制空泡。除了促进肌动蛋白重排的衣原体效应蛋白 TARP 磷酸蛋白外,很少有介导细菌进入和早期包含体建立的因素得到了描述。像许多 T3S 效应蛋白一样,TARP 需要伴侣蛋白(Slc1)才能有效地转运到宿主细胞中。在这项研究中,我们通过免疫沉淀结合质谱法确定了与侵袭性沙眼衣原体原体(EB)中的 Slc1 相关的蛋白质。我们鉴定了 Ct875,这是一种新的 Slc1 客户蛋白和 T3S 效应蛋白,我们将其重新命名为 TepP(早期转位磷酸蛋白)。我们提供的证据表明,T3S 效应蛋白在体外与 Slc1 形成大分子量复合物,并且 Slc1 在异源耶尔森氏菌 T3S 系统中增强了它们的 T3S 依赖性分泌。我们证明 TepP 在细菌进入上皮细胞的早期被转位,并被宿主激酶磷酸化酪氨酸残基。然而,TepP 磷酸化发生在 TARP 之后,再加上 Slc1 优先与 EB 中的 TARP 结合的发现,使我们推测这些效应蛋白在衣原体入侵过程中不同阶段被转运到宿主细胞中。在感染过程中,TepP 与支架蛋白 CrkI-II 共免疫沉淀,Crk 在进入部位被招募到 EB 中,在那里它仍然与新生包涵体相关联。重要的是,缺乏 TepP 的沙眼衣原体突变体未能将 CrkI-II 招募到包涵体中,这为该效应蛋白在招募宿主因子中的直接作用提供了遗传证实。最后,感染 tepP 突变体的宫颈上皮细胞显示与先天免疫反应相关的一组基因的表达发生改变。我们提出了一个模型,其中 TepP 作为 TARP 的下游因子,在进入部位招募支架蛋白,启动和放大对先天免疫反应的信号级联反应,这对调节沙眼衣原体的先天免疫反应很重要。